Human stem cells and drug screening: opportunities and challenges
Identifieur interne : 000690 ( Main/Exploration ); précédent : 000689; suivant : 000691Human stem cells and drug screening: opportunities and challenges
Auteurs : Allison D. Ebert [États-Unis] ; Clive N. Svendsen [États-Unis]Source :
- Nature Reviews Drug Discovery [ 1474-1776 ] ; 2010-05.
Abstract
High-throughput screening technologies are widely used in the early stages of drug discovery to rapidly evaluate the properties of thousands of compounds. However, they generally rely on testing compound libraries on highly proliferative immortalized or cancerous cell lines, which do not necessarily provide an accurate indication of the effects of compounds in normal human cells or the specific cell type under study. Recent advances in stem cell technology have the potential to allow production of a virtually limitless supply of normal human cells that can be differentiated into any specific cell type. Moreover, using induced pluripotent stem cell technology, they can also be generated from patients with specific disease traits, enabling more relevant modelling and drug screens. This article discusses the opportunities and challenges for the use of stem cells in drug screening with a focus on induced pluripotent stem cells.
Url:
DOI: 10.1038/nrd3000
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Human stem cells and drug screening: opportunities and challenges</title><author><name sortKey="Ebert, Allison D" sort="Ebert, Allison D" uniqKey="Ebert A" first="Allison D." last="Ebert">Allison D. Ebert</name></author><author><name sortKey="Svendsen, Clive N" sort="Svendsen, Clive N" uniqKey="Svendsen C" first="Clive N." last="Svendsen">Clive N. Svendsen</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:70414E8AA313302DADA9F25803F8D35B5C0DBCD2</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1038/nrd3000</idno><idno type="url">https://api.istex.fr/document/70414E8AA313302DADA9F25803F8D35B5C0DBCD2/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001113</idno><idno type="wicri:Area/Main/Curation">000F19</idno><idno type="wicri:Area/Main/Exploration">000690</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Human stem cells and drug screening: opportunities and challenges</title><author><name sortKey="Ebert, Allison D" sort="Ebert, Allison D" uniqKey="Ebert A" first="Allison D." last="Ebert">Allison D. Ebert</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>Allison D. Ebert is at the Stem Cell and Regenerative Medicine Center, University of WisconsinMadison, 1111 Highland Avenue, Wisconsin 53705</wicri:regionArea><wicri:noRegion>Wisconsin 53705</wicri:noRegion></affiliation></author><author><name sortKey="Svendsen, Clive N" sort="Svendsen, Clive N" uniqKey="Svendsen C" first="Clive N." last="Svendsen">Clive N. Svendsen</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>Clive N. Svendsen is at the Stem Cell and Regenerative Medicine Center, University of WisconsinMadison, and at the CedarsSinai Regenerative Medicine Institute, CedarsSinai Medical Center, 8700 Beverly Boulevard, Los Angeles, California 90048</wicri:regionArea><wicri:noRegion>California 90048</wicri:noRegion></affiliation><affiliation><wicri:noCountry code="no comma">E-mail: clive.svendsen@cshs.org</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Nature Reviews Drug Discovery</title><idno type="ISSN">1474-1776</idno><idno type="eISSN">1474-1784</idno><imprint><publisher>Nature Publishing Group</publisher><date type="published" when="2010-05">2010-05</date><biblScope unit="volume">9</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="367">367</biblScope><biblScope unit="page" to="372">372</biblScope></imprint><idno type="ISSN">1474-1776</idno></series><idno type="istex">70414E8AA313302DADA9F25803F8D35B5C0DBCD2</idno><idno type="DOI">10.1038/nrd3000</idno><idno type="ArticleID">nrd3000</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1474-1776</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">High-throughput screening technologies are widely used in the early stages of drug discovery to rapidly evaluate the properties of thousands of compounds. However, they generally rely on testing compound libraries on highly proliferative immortalized or cancerous cell lines, which do not necessarily provide an accurate indication of the effects of compounds in normal human cells or the specific cell type under study. Recent advances in stem cell technology have the potential to allow production of a virtually limitless supply of normal human cells that can be differentiated into any specific cell type. Moreover, using induced pluripotent stem cell technology, they can also be generated from patients with specific disease traits, enabling more relevant modelling and drug screens. This article discusses the opportunities and challenges for the use of stem cells in drug screening with a focus on induced pluripotent stem cells.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Ebert, Allison D" sort="Ebert, Allison D" uniqKey="Ebert A" first="Allison D." last="Ebert">Allison D. Ebert</name></noRegion><name sortKey="Svendsen, Clive N" sort="Svendsen, Clive N" uniqKey="Svendsen C" first="Clive N." last="Svendsen">Clive N. Svendsen</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000690 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000690 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:70414E8AA313302DADA9F25803F8D35B5C0DBCD2
|texte= Human stem cells and drug screening: opportunities and challenges
}}
| This area was generated with Dilib version V0.6.23. |  |